Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Study to Investigate the Humoral and Cellular Immune Response to Two Doses of VAX102 Influenza Vaccine in Healthy Adults

NCT00921206 is registered in ClinicalTrials.gov with VaxInnate Corporation as lead sponsor.

NCT NCT00921206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00921206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Study to Investigate the Humoral and Cellular Immune Response to Two Doses of VAX102 Influenza Vaccine in Healthy Adults
Lead sponsor
VaxInnate Corporation
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2009
Completion date
December 31, 2009
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza